These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9723407)

  • 1. Treatment of recurrent hepatitis C virus infection after liver transplantation with interferon and ribavirin.
    Götz G; Schön MR; Haefker A; Neuhaus R; Berg T; Hopf U; Neuhaus P
    Transplant Proc; 1998 Aug; 30(5):2104-6. PubMed ID: 9723407
    [No Abstract]   [Full Text] [Related]  

  • 2. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
    Charlton M; Gane E; Manns MP; Brown RS; Curry MP; Kwo PY; Fontana RJ; Gilroy R; Teperman L; Muir AJ; McHutchison JG; Symonds WT; Brainard D; Kirby B; Dvory-Sobol H; Denning J; Arterburn S; Samuel D; Forns X; Terrault NA
    Gastroenterology; 2015 Jan; 148(1):108-17. PubMed ID: 25304641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
    Curry MP; Forns X; Chung RT; Terrault NA; Brown R; Fenkel JM; Gordon F; O'Leary J; Kuo A; Schiano T; Everson G; Schiff E; Befeler A; Gane E; Saab S; McHutchison JG; Subramanian GM; Symonds WT; Denning J; McNair L; Arterburn S; Svarovskaia E; Moonka D; Afdhal N
    Gastroenterology; 2015 Jan; 148(1):100-107.e1. PubMed ID: 25261839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination.
    Mazzaferro V; Regalia E; Pulvirenti A; Tagger A; Andreola S; Pasquali M; Baratti D; Romano F; Palazzo U; Zuin M; Bonino F; Ribero ML; Gennari L
    Transplant Proc; 1997; 29(1-2):519-21. PubMed ID: 9123113
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of interferon based antiviral therapy for recurrent hepatitis C in patients who received steroid free immunosuppression for liver transplantation.
    Nair S; Lipscomb J; Eason J
    Transplantation; 2008 Aug; 86(3):418-22. PubMed ID: 18698245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin G4-associated de novo autoimmune hepatitis after liver transplantation for chronic hepatitis B- and C-related cirrhosis and hepatocellular carcinoma: a case report with literature review.
    Zhao XY; Rakhda MI; Wang TI; Jia JD
    Transplant Proc; 2013 Mar; 45(2):824-7. PubMed ID: 23498828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy for chronic hepatitis C: interferon and ribavirin.
    Christie JM; Chapman RW
    Hosp Med; 1999 May; 60(5):357-61. PubMed ID: 10396412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect and safety of the treatment of recurrent hepatitis C infection after orthotopic liver transplantation with pegylated interferon α2b and ribavirin.
    Perrakis A; Yedibela S; Schuhmann S; Croner R; Schellerer V; Demir R; Hohenberger W; Müller V
    Transplant Proc; 2011 Dec; 43(10):3824-8. PubMed ID: 22172854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe recurrent hepatitis C after liver transplantation with ribavirin plus interferon alpha.
    Fischer L; Sterneck M; Valentin-Gamazo C; Feucht HH; Malagó M; Broelsch CE
    Transplant Proc; 1999; 31(1-2):494-5. PubMed ID: 10083207
    [No Abstract]   [Full Text] [Related]  

  • 10. Sustained clearance of serum hepatitis C virus-RNA independently predicts long-term survival in liver transplant patients with recurrent hepatitis C.
    Kornberg A; Küpper B; Tannapfel A; Thrum K; Bärthel E; Habrecht O; Settmacher U
    Transplantation; 2008 Aug; 86(3):469-73. PubMed ID: 18698252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High sustained virological response to pegylated interferon and ribavirin for recurrent genotype 3 hepatitis C infection post-liver transplantation.
    Faisal N; Mumtaz K; Marquez M; Renner EL; Lilly LB
    Hepatol Int; 2015 Jan; 9(1):76-83. PubMed ID: 25788382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Successful elimination of hepatitis C virus after hepatic lobectomy in a patient with hepatocellular carcinoma].
    Wimmer A; Fehér J; Lengyel G
    Orv Hetil; 2008 Nov; 149(45):2143-8. PubMed ID: 18977742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation.
    Castells L; Vargas V; Allende H; Bilbao I; Luis Lázaro J; Margarit C; Esteban R; Guardia J
    J Hepatol; 2005 Jul; 43(1):53-9. PubMed ID: 15876467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of telaprevir on the pharmacokinetics of sirolimus in liver transplant recipients.
    O'Leary JG; McKenna GJ; Klintmalm GB; Davis GL
    Liver Transpl; 2013 Apr; 19(4):463-5. PubMed ID: 23408534
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of recurrent hepatitis C virus infection after liver transplantation].
    Lengyel G; Tulassay Z
    Orv Hetil; 2007 Oct; 148(40):1875-81. PubMed ID: 17905682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy of interferon alpha-2B and ribavirin for recurrent hepatitis C after liver transplantation.
    Castedal M; Siewert-Delle A; Olausson M; Friman S
    Transplant Proc; 2003 Mar; 35(2):820-1. PubMed ID: 12644153
    [No Abstract]   [Full Text] [Related]  

  • 17. Triple antiviral therapy with amantadine for IFN-ribavirin nonresponders with recurrent posttransplantation hepatitis C.
    Bizollon T; Adham M; Pradat P; Chevallier M; Ducerf C; Baulieux J; Zoulim F; Trepo C
    Transplantation; 2005 Feb; 79(3):325-9. PubMed ID: 15699763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches to the treatment of hepatitis C virus infection after liver transplantation using ribavirin.
    Bizollon T; Ducerf C; Trépo C
    J Hepatol; 1995; 23 Suppl 2():22-5. PubMed ID: 8720290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent hepatitis C following liver transplant: diagnosis, natural history, and therapeutic options.
    Saab S; Wang V
    J Clin Gastroenterol; 2003 Aug; 37(2):155-63. PubMed ID: 12869888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C.
    Wiesner RH; Sorrell M; Villamil F;
    Liver Transpl; 2003 Nov; 9(11):S1-9. PubMed ID: 14586888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.